Parmax Pharma has informed that it has enclosed the voting results and Consolidated Scrutinizers Report of Postal Ballot for resolution relating to: Issue, offer and allot equity shares on preferential basis to promoters; Issue, offer and allot equity shares on preferential basis to non-promoter entities; Issue, offer and allot equity shares on preferential basis to public entities. The aforesaid resolution has not been passed through Postal Ballot and e-voting by Members with requisite majority.
The above information is a part of company’s filings submitted to BSE.
